THERAKOS CELLEX PHOTOPHRESES SYSTEM
FDA premarket approval P860003/S068 · decided 2013-05-01
Approval details
- PMA number
- P860003
- Supplement
- S068
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- THERAKOS CELLEX PHOTOPHRESES SYSTEM
- Generic name
- System, photopheresis, extracorporeal
- Applicant
- Therakos Development Limited
- Date received
- 2012-11-06
- Decision date
- 2013-05-01
- Days to decision
- 176 days
- Decision code
- APPR
- Product code
- LNR
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Dublin
- Statement
- APPROVAL FOR SOFTWARE CHANGES TO THE THERAKOS® CELLEX® PHOTOPHERESIS SYSTEM (SOFTWARE VERSION 4.1).
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.